PENCIL BIOSCIENCES Trademark
Trademark Overview
On Friday, March 15, 2024, a trademark application was filed for PENCIL BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the PENCIL BIOSCIENCES trademark a serial number of 98450944. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 17, 2024. This trademark is owned by Pencil Biosciences Ltd. The PENCIL BIOSCIENCES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Therapeutic and prophylactic pharmaceutical products for use in the treatment of cancer, genetic diseases, rare diseases, neurodegenerative diseases and diseases of the immune system; pharmaceutical substances and preparations for use in the treatment of cancer, genetic diseases, rare diseases, neurodegenerative diseases and diseases of the immune system; enzymes and enzyme preparations for medical uses; vectors being gene therapy viral vectors or DNA plasmids for the delivery of genes to cells, all for medical purposes; genetically modified cells for medical use for the treatment of cancer, genetic diseases, rare diseases, neurodegenerative diseases and diseases of the immune system; vectors being gene therapy viral vectors or DNA plasmids for medical use; cell cultures, peptides, proteins, nucleic acids, modified nucleic acids, ribonucleotide protein, mRNA or complexes of these molecules for medical use.
Scientific, pharmaceutical and medical research and development in the field of gene modification, gene editing, gene correction, gene repair, gene modulation, cell therapy, cellular modification and gene therapy; genetic engineering services, biotechnology services, advisory services relating to cell therapy and gene therapy products; consultancy and advisory services relating to the aforesaid services.
General Information
Serial Number | 98450944 |
Word Mark | PENCIL BIOSCIENCES |
Filing Date | Friday, March 15, 2024 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, December 17, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, December 17, 2024 |
Trademark Statements
Goods and Services | Therapeutic and prophylactic pharmaceutical products for use in the treatment of cancer, genetic diseases, rare diseases, neurodegenerative diseases and diseases of the immune system; pharmaceutical substances and preparations for use in the treatment of cancer, genetic diseases, rare diseases, neurodegenerative diseases and diseases of the immune system; enzymes and enzyme preparations for medical uses; vectors being gene therapy viral vectors or DNA plasmids for the delivery of genes to cells, all for medical purposes; genetically modified cells for medical use for the treatment of cancer, genetic diseases, rare diseases, neurodegenerative diseases and diseases of the immune system; vectors being gene therapy viral vectors or DNA plasmids for medical use; cell cultures, peptides, proteins, nucleic acids, modified nucleic acids, ribonucleotide protein, mRNA or complexes of these molecules for medical use. |
NOT AVAILABLE | BIOSCIENCES |
Goods and Services | Scientific, pharmaceutical and medical research and development in the field of gene modification, gene editing, gene correction, gene repair, gene modulation, cell therapy, cellular modification and gene therapy; genetic engineering services, biotechnology services, advisory services relating to cell therapy and gene therapy products; consultancy and advisory services relating to the aforesaid services. |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, March 15, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, March 15, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Pencil Biosciences Ltd |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 16 - Limited Liability Company |
Address | Macclesfield, Cheshire SK104TG GB |
Party Name | Pencil Biosciences Ltd |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Macclesfield, Cheshire SK104TG GB |
Trademark Events
Event Date | Event Description |
Sunday, March 17, 2024 | NEW APPLICATION ENTERED |
Thursday, August 8, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, September 25, 2024 | ASSIGNED TO EXAMINER |
Thursday, September 26, 2024 | NON-FINAL ACTION E-MAILED |
Thursday, September 26, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, September 26, 2024 | NON-FINAL ACTION WRITTEN |
Monday, November 4, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, November 4, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, November 4, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, November 6, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, November 14, 2024 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
Wednesday, December 11, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, December 17, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, December 17, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |